CTX is a filamentous bacteriophage that encodes cholera toxin. CTX infection of its host bacterium, Vibrio cholerae, requires the toxin-coregulated pilus (TCP) and the products of the V. cholerae tolQRA genes. Here, we have explored the role of OrfU, a predicted CTX minor coat protein, in CTX infection. Prior to the discovery that it was part of a prophage, orfU was initially described as an open reading frame of unknown function that lacked similarity to known protein sequences. Based on its size and position in the CTX genome, we hypothesized that OrfU may function in a manner similar to that of the coliphage fd protein pIII and mediate CTX infection as well as playing a role in CTX assembly and release. Deletion of orfU from CTX dramatically reduced the number of CTX virions detected in supernatants from CTX-bearing cells. This defect was complemented by expression of orfU in trans, thereby confirming a role for this gene in CTX assembly and/or release. To evaluate the requirement for OrfU in CTX infection, we introduced fragments of orfU into gIII in an fd derivative to create OrfU-pIII fusions. While fd is ordinarily unable to infect V. cholerae, an fd phage displaying the N-terminal 274 amino acids of OrfU could infect V. cholerae in a TCP-and TolA-dependent fashion. Since our findings indicate that OrfU functions as the CTX pIII, we propose to rename OrfU as pIII CTX . Our data also provide new evidence for a conserved pathway for filamentous phage infection.
The molecular interactions that mediate the entry of Escherichia coli-derived filamentous phages into their hosts have been studied in considerable detail. pIII, a phage minor coat protein found on one tip of the virion, accounts for host specificity in both N-pilus (IKE and I2-2)-and F-pilus (Ff)-specific phages (fd, f1, M13) (3, 8, 11, 24) . The initial step in Ff phage infection is mediated by the binding of pIII to the tip of the F pilus (19) . The Ff phages do not absolutely require the F pilus for infection; however, Ff infection of F Ϫ E. coli occurs at much reduced frequencies (32) . The binding of pIII to F is thought to result in pilus retraction, which brings the phage particle in close proximity to and perhaps through the bacterium's outer membrane. Subsequent translocation of Ff DNA through the periplasm and inner membrane requires the products of the tolQRA genes both in F ϩ and in F Ϫ E. coli (32, 36, 37) . Recent studies suggest that, in addition to binding to the pilus, pIII also binds to TolA, which serves as a coreceptor (4, 30) . Although the exact role of TolQ and TolR in the infection process is unknown, they appear to interact with TolA through their inner membrane spanning regions (9, 21) , and they may ordinarily constitute a channel for importing as yet unknown substrates across the inner membrane (42) . Following the TolA-pIII interaction, pVIII, the Ff major coat protein, is inserted into the host cell inner membrane, and the phage DNA is translocated into the cytoplasm of the host cell (5, 33) .
The 424-amino-acid Ff pIII is thought to consist of a leader sequence (2) and three domains, separated by glycine-rich regions, that serve distinct roles in phage entry and release. The first two pIII domains, designated g3p-D1 (residues 1 to 86) and g3p-D2 (residues 105 to 236), are required for Ff adsorption and entry (7, 30, 35) , while the third domain, g3p-D3 (residues 270 to 406), is required for the assembly and release of Ff particles from host cells (6, 29) . g3p-D1, the "penetration" domain, and g3p-D2, the "adsorption" domain, have been shown to bind to the Ff coreceptors TolA and F, respectively. Holliger and coworkers have proposed that following binding of g3p-D2 to F, the conformation of pIII changes and that this shift reveals the TolA binding site in g3p-D1. Thus, Ff infection is thought of as a two-step process in which different domains of pIII sequentially bind to F and then to TolA (16, 23) .
The C terminus of pIII (g3p-D3) has been implicated in the assembly of Ff particles and in their release from the bacterial membrane. In the absence of pIII, Ff virions remain attached to the cell surface in long "polyphages" (6, 22, 28, 29) . According to the model of Rakonjac et al. (28) , pIII and pVI (another minor coat protein) are incorporated into assembling phage particles through interactions with pVIII to form a "pretermination complex." Only the last 83 amino acids of pIII are required to form this complex. A conformational change in g3p-D3 may disrupt the association of pIII with the inner membrane, enabling capping and release of virions. g3p-D3 is also required for the production of stable virions that are resistant to certain detergents (28) .
CTX is a Vibrio cholerae-derived lysogenic filamentous phage that contains ctxAB, the operon encoding cholera toxin, in its 7-kb genome. Nontoxigenic V. cholerae strains can be converted to toxigenicity by CTX infection (41) . As in Ff infection of E. coli, CTX infection of V. cholerae requires a cell surface pilus, toxin-coregulated pilus (TCP), and the periplasmic/inner membrane protein complex TolQRA (13) . TCP is a type IV bundle-forming pilus that is also required for V. cholerae intestinal colonization (38) . We and others previously found that inactivation of either tcpA or the tolQRA genes of V. cholerae reduced CTX infection by more than 3 orders of magnitude (13, 41) . Given the similarities of the requirements for CTX infection of V. cholerae to those for Ff infection of E. coli, we hypothesized that CTX might contain a virion coat protein that functions analogously to pIII and interacts with TCP and the TolQRA complex to enable CTX infection of V. cholerae.
The CTX core region encodes proteins for virion morphogenesis, including the putative major coat protein (Cep), three putative minor coat proteins (Psh, OrfU, and Ace), and Zot (20) , which is similar to the Ff protein pI and is required for phage assembly and secretion. Although several of the putative CTX gene products bear similarity to known filamentous phage proteins, none of the CTX genes encode a protein similar in sequence to pIII. However, since pIII and OrfU have similar sizes and positions within their respective genomes (immediately 3Ј of the gene encoding the major coat protein), we hypothesized that OrfU is the CTX pIII homologue. Recently, Holliger and Reichmann determined the solution structure of g3p-D1 by nuclear magnetic resonance spectroscopy. They predicted that residues 18 to 86 of OrfU may fold into a ␤ barrel similar to that of g3p-D1 (15) . Their analysis lends additional credence to the hypothesis that OrfU is the CTX pIII equivalent and to introducing the idea that these particular OrfU residues are involved in the binding of OrfU to the V. cholerae TolA (15) . To test the hypothesis that OrfU mediates CTX infection, we "displayed" OrfU on the surface of an Ff phage as an OrfU-pIII fusion protein. The resulting phage infected both F ϩ E. coli and TCP ϩ V. cholerae. Furthermore, OrfU was found to be required for CTX production by V. cholerae. These findings indicate that OrfU functions as the CTX pIII analogue, and we propose to rename OrfU as pIII CTX .
MATERIALS AND METHODS
Strains, media, and antibiotics. The bacterial strains used in this study are listed in Table 1 . Bacteria were grown in Luria-Bertani (LB) broth at 37°C. To induce TCP production, the classical V. cholerae strain O395 was grown on a roller drum shaker at 30°C as previously described (13) . To ensure F pilus production by E. coli strain TG1, the strain was maintained on M9 minimal medium plates containing glucose. Antibiotics were used at the following concentrations: ampicillin, 50 g/ml (V. cholerae) and 100 g/ml (E. coli); streptomycin, 200 g/ml; kanamycin, 50 g/ml; chloramphenicol, 15 g/ml (E. coli) and 1 g/ml (V. cholerae); tetracycline, 20 g/ml (E. coli) and 1 g/ml (V. cholerae). Arabinose (Ara) (0.02%) was added to LB broth to induce expression of genes under the control of the pBAD promoter.
Construction of pCTX-Kan⌬orfU and an orfU expression plasmid. An inframe deletion of orfU in pCTX-Kan was constructed using the PCR technique of splicing by overlapping extension (18) . The two outside primers were DelUA (5Ј GCGATAAGGGGCTTTATTGGTATG 3Ј) and DelUD (5Ј CATTCGTG ATGATGTGACGGC 3Ј). The two internal primers were DelUB2 (5Ј GAGC ATGGCGGCCAGAAAAAAGGGCGAACG 3Ј) and DelUC2 (5Ј CGTTCG CCCTTTTTTCTGGCCATGCTC 3Ј). After subcloning of the deletion PCR product into pCRII-TOPO, an AscI/PmlI fragment from this plasmid was ligated Transduction assay. CTX-Kn and CTX-Kn⌬orfU transducing particles were enumerated using a previously described transduction assay (13) . Briefly, filtered supernatants were prepared from cultures grown to an optical density at 600 nm (OD 600 ) of approximately 0.8. A 75-l volume of the filtered supernatants from these cultures was mixed with 75 l of TCP ϩ O395 cells for 20 min at room temperature on a shaker. Each mixture was then plated on LB agar containing either streptomycin, to enumerate the number of recipient cells, or kanamycin, to enumerate the transductants. The transduction frequency was calculated by dividing the number of transductants by the number of recipients. Similar transduction assays were used to calculate the numbers of the fd-derived transducing phages we studied here. To prepare these phages, DH5␣pir harboring the different fd-derived phages was grown overnight in LB broth and tetracycline. Phage particles were then precipitated from filtered supernatants with 5% polyethylene glycol (PEG) in 2.5 M NaCl overnight at 4°C, followed by centrifugation at 10,000 ϫ g for 30 min. The particles were then resuspended in LB broth. To enumerate transductants, cell mixtures were plated on LB agar plates containing tetracycline, and to enumerate recipients, the mixtures were plated on LB plates either alone (for TG1) or with streptomycin (for the V. cholerae strains). The transduction frequency was calculated as described above.
Detection of phage DNA in supernatants. Southern blot analysis was used to detect phage DNA in filtered supernatants from mid-log-phase cultures of Bah3 harboring pCTX-Kn derivatives. The phage particles were PEG precipitated as described above and then resuspended in a sodium dodecyl sulfate (SDS)-containing buffer (1% SDS, 1ϫ Tris-acetate-EDTA [TAE], 5% glycerol, 0.25% loading dye) at 70°C for 20 min to disrupt virions (29) . These preparations were then subjected to 1% agarose electrophoresis, and CTX DNA was then detected by Southern analysis using the CTX rstB gene as a probe. The rstB gene was amplified with primers RstBF (5Ј ATGAAATTATGGGTGATTAAT 3Ј) and RstBB (5Ј CCACCGCGAAATAGAGCGCCT 3Ј). For the nondenaturing Southern blots, the NaOH treatment of the gel was omitted prior to transfer.
Construction of fd-DOG derivatives containing OrfU-pIII fusions. Our strategy was to amplify different regions of orfU and subclone them into the pcDNA3.1/Myc(Ϫ)B vector to add a myc epitope to the 3Ј end of the construct. We then inserted this downstream of the leader sequence of gIII in fd-DOG. The primers used for these constructs are listed in Table 2 . After the first round of amplification, the PCR products were ligated into the TA cloning vector pCRII-TOPO according to the manufacturer's protocol. An ApaI/XbaI fragment from each of the resulting plasmids was then ligated to ApaI/XbaI-digested pcDNA3.1/ Myc(Ϫ)B vector. These myc fusion constructs were PCR amplified with the original forward primer and the reverse primer MycR (5Ј GCGGCCGCCAGA TCCTCTTC 3Ј). Following subcloning into pCRII-TOPO, an ApaLI/NotI fragment was ligated into ApaLI/NotI-digested fd-DOG. This scheme resulted in the insertion of orfU fragments, an extra CTA (leucine), and a myc tag immediately 3Ј of the pIII signal sequence (see Fig. 2B ).
pIII-OrfU fusions that lacked the adsorption (g3p-D2) and the penetration (g3p-D1) domains of pIII were also generated. First, a NotI site was introduced into the pIII-OrfU fusion construct just upstream of the linker sequence which separates g3pD2 and g3pD3. The NotI site was added by using the QuikChange XL Site-Directed Mutagenesis kit and the NotIF primer (5Ј CCTCCTGTC AATGCGGCCGCAGGCTCTGGTGGTGG 3Ј) and its reverse complement, NotIR. The resulting plasmids were digested with NotI to release the g3pD1D2 fragment and were then religated to form the fd⌬1 constructs.
Molecular biology methods. Standard molecular biology methods were used in this study (1) . Restriction enzymes and T4 DNA ligase were purchased from New England Biolabs (Beverly, Mass.). For the Western blot analyses, the anti-myc antibody was purchased from Invitrogen and the anti-pVIII antibody was purchased from Stratagene (La Jolla, Calif.). Southern hybridization was carried out with the ECL direct nucleic acid labeling and detection system (Amersham Pharmacia, Little Chalfont, Buckinghamshire, England) according to the manufacturer's instructions. The low-complexity regions of pIII and OrfU were analyzed by the "Predictprotein" program at the EMBL Heidelberg website (www.embl-heidelberg.de/predictprotein/predictprotein.html) (44) .
RESULTS
Requirement for OrfU for CTX production. To begin to study the role of OrfU in CTX virion morphogenesis and infectivity, we made an in-frame orfU deletion in pCTX-Kn, the plasmid form of a kanamycin-marked CTX. This deletion removed all of orfU except for the sequence encoding the final nine amino acids. This deletion mutant was electroporated into the classical strain O395, which contains a defective prophage, and Bah3, which lacks a CTX prophage and a phage attachment site. Compared to Bah3(pCTX-Kn), no infectious particles were detected in filtered supernatants of Bah3(pCTX-
Comparison of the amounts of phage and plasmid DNA present in orfU ϩ and orfU mutant CTX derivatives by Southern blot analysis using an rstB probe. The samples shown in panel A were denatured in NaOH prior to transfer to the nylon membrane; samples in panel B were not denatured. Lanes 1 and 7 and lanes 2 and 8 contain PmlI-digested plasmid DNA of pCTX-Kn and pCTX-Kn⌬orfU, respectively. The remaining lanes are preparations of phage DNA from filtered supernatants: lanes 3 and 9, Bah3(pCTX-Kn); lanes 4 and 10, Bah3(pCTX-Kn⌬orfU); lanes 5 and 11, Bah3(pCTX-Kn⌬orfU/ pDH5.52 ϩ 0.02% Ara); lanes 6 and 12, Bah3(pCTX-Kn ⌬orfU/ pDH5.52 without Ara). After a longer exposure, a faint band with an apparent molecular weight identical to that of the lower band seen in lane 2 was evident in lane 4. The first six amino acids of the first line are the first amino acids of OrfU located downstream of the pIII leader sequence. The first six amino acids of the second line are the last OrfU amino acids in the construct. The L is the leucine which is incorporated into each construct due to our cloning strategy; it is followed by the amino acids of the Myc tag, which are not shown. (44) . The amino acids in red are these low-complexity regions (LCRs). The areas of LCR for OrfU are from residues 116 to 134 and 252 to 268, and those for pIII are from residues 86 to 104 and 246 to 272. These LCRs of pIII have been previously designated as the linkers that separate the three domains of pIII (15) . (B) (Top) Schematic representations of three pIII domains and the three regions in OrfU separated by LCRs. The boundaries for the LCRs of OrfU were determined from the analysis described Kn⌬orfU) ( Table 3 , third and fourth rows). This defect in CTX production could be complemented in trans by producing OrfU from a defective CTX prophage (in the classical strain O395) or from a plasmid, pDH5.52 (Table 3 , second and sixth rows). For the latter experiments, we expressed orfU from the arabinose-inducible promoter pBAD on pDH5.52 in Bah3 (pCTX-Kn⌬orfU). When arabinose was added to Bah3(pCTXKn⌬orfU/pDH5.52), infectious CTX-Kn was produced at levels comparable to those observed for wild-type CTX virions (Table 3 ; compare sixth row with third row). As expected, virions produced following introduction of exogenous OrfU still carried the orfU deletion and continued to be dependent upon a complementing OrfU for virion production in new hosts infected with CTX-Kn⌬orfU (data not shown). These results indicate that OrfU is required for the production of infectious CTXs.
Since pIII is required for Ff phage assembly and release, the absence of Kn-transducing particles in supernatants from Bah3 (pCTX-Kn⌬orfU) was potentially attributable to a lack of production of CTX-Kn⌬orfU virions by this strain. An alternate possibility was that Bah3(pCTX-Kn⌬orfU) produced virions that were incapable of infecting a recipient strain. To distinguish between these alternatives, we tested supernatants of Bah3 cells harboring either pCTX-Kn or pCTX-Kn⌬orfU for the presence of single-stranded phage DNA by Southern blot analysis. Bah3(pCTX-Kn) supernatants contained abundant CTX-hybridizing DNA that could be detected even if the DNA was not denatured with NaOH after electrophoresis, suggesting that the hybridizing species was single-stranded phage DNA (Fig. 1, lanes 3 and 9) . In marked contrast, very little CTX-hybridizing DNA was detected in supernatants from cells harboring pCTX-Kn⌬orfU (Fig. 1, lanes 4 and 10) . However, as in the previous experiment, expression of orfU in trans restored levels of secreted DNA to wild-type levels (Fig.  1, lanes 5 and 11) . The reduction in phage production by Bah3 (pCTX-Kn⌬orfU) supernatants was not due to a replication defect of pCTX-Kn⌬orfU, since pCTX-Kn⌬orfU replicated as well as pCTX-Kn. Approximately equal amounts of both the single-and double-stranded forms of phage DNA were detected in plasmid preparations of Bah3(pCTX-Kn) and Bah3 (pCTX-Kn⌬orfU) (Fig. 1, lanes 1 and 2) . These data suggest that the lack of infectious CTX-Kn in supernatants from Bah3(pCTX-Kn⌬orfU) results primarily from a failure in the assembly and/or release of CTX particles. However, since the small number of virions secreted from Bah3(pCTX-Kn⌬orfU) did not yield any transductants, it appears that OrfU is also necessary for CTX to infect a new host.
The role of OrfU in CTX infection. To investigate whether OrfU functions in CTX infection, we introduced fragments of orfU into gIII in a tetracycline-marked fd derivative, fd-DOG, that was previously used as a phage display vector (17) . This resulted in display of OrfU fused to pIII on the surface of fd-DOG. We adopted this approach for three reasons. First, this method circumvents the requirement for OrfU in CTX production by V. cholerae because the recombinant fd phages utilize the pIII portion of the fusion protein to be released from E. coli. Second, fd virions containing pIII fusion proteins often retain normal levels of infectivity for F ϩ E. coli, so phages that failed to infect V. cholerae could still be titered on E. coli (34) . Third, we knew that although fd alone cannot infect V. cholerae, it is capable of replication in V. cholerae when introduced by electroporation (unpublished data). Thus, by producing different pIII-OrfU fusion proteins on the surface of fd, we tested whether various portions of OrfU could enable fd to infect V. cholerae.
We compared the amino acid sequences of OrfU and pIII in order to choose segments of OrfU to fuse to pIII. The three functional domains of pIII are separated by stretches of glycine-rich residues that are thought to constitute regions of minimal structural complexity functioning as flexible linkers (16) . No such glycine-rich stretches are found in the OrfU sequence; however, there are two regions rich in prolines and serines that could separate OrfU into functionally distinct domains similar in size to those found in pIII. According to the computer algorithm "Predictprotein," these regions (residues 116 to 134 and 252 to 269) in OrfU are unlikely to form a secondary structure ( Fig. 2A) and therefore may act as linkers between OrfU domains. This algorithm accurately defined the residues that constitute the linker within pIII (Fig. 2A) .
We initially fused the first two-thirds of the orfU coding region to gIII in fd-DOG. As shown at the top of Fig. 2B , this segment of OrfU included the amino acids through the end of the second putative low-complexity region ( Fig. 2A) . This region was chosen because only the N-terminal two-thirds of pIII, which includes g3p-D1 and g3p-D2, mediates Ff infection of E. coli (29, 30, 35) . The orfU N-terminal fragment was introduced 3Ј of the gIII signal sequence and 5Ј of the complete gIII coding sequence in fd-DOG, generating fd-pIII CTX (15- b Calculated by dividing the number of transductants (Kn r colonies) by the number of O395 recipients. The transduction assays were conducted at least three times, and the mean frequency is presented. The standard deviations of these values were less than 10% of the means.
in the legend to panel A. The residues for the linkers of pIII are as previously described. (Bottom) Schematic of the six pIII-OrfU fusions used to investigate the regions of OrfU required to expand the host range of fd to include V. cholerae. Light blue boxes represent the myc tag added to the 3Ј end of orfU in each of the fusions. The transduction frequencies were calculated by dividing the number of transductants (tetracyclineresistant colonies) by the number of recipient cells. The TCP ϩ and TCP Ϫ V. cholerae recipients were O395 and TCP2, respectively. TG1 was the F ϩ E. coli recipient. The transduction frequencies represent the means from at least three experiments, and all standard deviations were less than 10%. UD, undetectable. (Fig. 2B, row 2) . A myc tag was inserted at the same time to facilitate detection of the fusion protein (Fig. 2B, row 2) . The fd-pIII CTX (15-274) virion was predicted to contain part of OrfU linked to pIII on one tip of the fd virion (10, 25) . The OrfU fragment fused to pIII in fd-pIII CTX (15-274) did not alter this phage's ability to infect E. coli; fd-pIII CTX (15-274) infected the F ϩ E. coli strain TG1 as well as fd-DOG did ( Fig.  2B; compare rows 1 and 2) . However, unlike supernatants from a strain producing fd-DOG (Fig. 2B, row 1) , filtered supernatants from an E. coli strain harboring fd-pIII CTX (15-274) could be used to infect V. cholerae (Fig. 2B, row 2) . Thus, the N-terminal two-thirds of the OrfU polypeptide fused to pIII is sufficient for expanding the host range of a phage that was previously restricted to F ϩ E. coli. The ability of fdpIII CTX (15-274) to infect V. cholerae was dependent on TCP and TolA, the known CTX coreceptors, as the efficiency of infection by fd-pIII CTX (15-274) of a V. cholerae strain lacking TCP was reduced by 3 orders of magnitude (Fig. 2B, row 2) . The infection of a tolA mutant strain (O395 tolA::pGP704) was below the levels of detection for this assay (Ͻ10 Ϫ9 ). Taken together, these data suggest that OrfU mediates CTX infection of V. cholerae and that amino acids 15 to 274 of OrfU contain regions that interact with TCP and TolA.
To be certain that the pIII portion of the OrfU-pIII fusion protein did not contribute to infection of V. cholerae by fd-pIII CTX (15-274), we constructed a derivative of this phage, fd⌬1-pIII CTX , that lacks g3p-D1 and g3p-D2 (Fig. 2B,  row 3) . Elimination of these pIII domains did not prevent fd⌬1-pIII CTX (15-274) from infecting V. cholerae (Fig. 2B, row  3) . In fact, this deletion appears to enhance the infectivity of fd⌬1-pIII CTX (15-274) relative to fd-pIII CTX (15-274) for both TCP ϩ and TCP Ϫ V. cholerae ( Fig. 2B ; compare rows 2 and 3). Thus, the pIII adsorption (g3p-D2) and penetration (g3p-D1) domains do not contribute to the ability of fd-pIII CTX (15-274) to infect V. cholerae. The reason why fd⌬1-pIII CTX (15-274) infected V. cholerae at a greater efficiency than fd-pIII CTX (15-274) is not clear. It is not likely that unequal numbers of virions were added to the V. cholerae recipients. Western blot analysis of phage proteins with anti-pVIII antisera suggested that approximately equivalent numbers of virions were used in each infection experiment (Fig. 3 , bottom panel, first and fifth lanes; also data not shown). Perhaps residues in g3pD1D2 in the pIII-OrfU(15-274) fusion protein sterically hinder OrfU residues from interacting with TCP and/or TolA.
The data presented above suggest that residues 15 to 274 of OrfU contain a region(s) that interacts with both TCP and TolA. Based on the sequence analysis shown in Fig. 2A and on experimental studies of pIII, we investigated whether these 259 amino acids could be subdivided into an adsorption domain, for binding the pilus, and a penetration domain, for binding TolA. To test whether the segments flanked by the low-complexity regions can function as autonomous domains, we constructed recombinant fd phages containing OrfU residues 15 to 138 [fd-pIII CTX ] and 117 to 274 [fd-pIII CTX (117-274)] fused to pIII (Fig. 2B , rows 4 and 6, respectively) by using the same cloning strategy that we followed to construct fd-pIII CTX . Derivatives of these new phages that lacked g3p-D1 and g3p-D2 were also generated and designated fd⌬1. Both fd-pIII CTX In contrast to the fd derivatives bearing OrfU residues 15 to 138, those fd derivatives that displayed only residues 117 to 274 of OrfU could not infect V. cholerae (Fig. 2B, rows 6 and 7) . As judged from the Western blots in Fig. 3 , the failure of fd-pIII CTX (117-274) and fd⌬1-pIII CTX (117-274) to infect V. cholerae was not due to low viral titers or degradation of the pIII-OrfU fusion protein. Phages displaying OrfU residues 117 to 274 appear to be as abundant as the other fd derivatives, and they contain a gIII fusion protein of the expected size. It is therefore likely that these fd derivatives were not able to infect V. cholerae because they do not contain OrfU residues 15 to 139 and consequently cannot bind to TolA. Ff derivatives that lack the pIII TolA binding domain are similarly unable to infect E. coli. It is not clear whether fd-pIII CTX (117-274) and fd⌬1-pIII CTX (117-274) are able to bind to TCP. The experiments presented above suggest that OrfU amino acids 117 to 274 are necessary for binding to TCP, but we have not yet determined whether these amino acids are sufficient.
DISCUSSION
We found that OrfU is required for assembly and/or release of CTX virions by V. cholerae and that display of a part of OrfU on fd is sufficient to enable fd to enter V. cholerae. These results suggest that OrfU functions as the pIII equivalent for CTX. orfU was first described as the open reading frame immediately 5Ј of ace several years prior to the discovery of CTX (40) ; it was designated orfU because its function was unknown. Given our findings, we propose to rename OrfU as pIII CTX , which both appear to contain a TCP binding domain. Thus, in the absence of TCP, the putative pIII CTX adsorption domain (residues 139 to 274) may inhibit the penetration domain (amino acids 15 to 138) from binding to TolA. If this model is correct, it suggests that the underlying mechanisms of CTX and Ff infection of their respective hosts are conserved. However, given the lack of similarity in the amino acid sequences of pIII CTX and pIII fd , such conservation would probably be based on similarities in the molecular structures of these virion minor coat proteins. pIII CTX is usually required for CTX assembly and release, as well as for CTX infection; however, we were unable to localize the assembly and release functions to a particular segment of the protein. While production of full-length pIII CTX from a plasmid could facilitate release of CTX-Kn⌬orfU particles from a strain harboring pCTX-Kn⌬orfU (Fig. 1) , production of the C-terminal two-thirds of pIII CTX did not (data not shown). Therefore, most or even all of pIII CTX seems to be required for assembly and release of CTX particles; in contrast, only the C-terminal 80 amino acids of pIII are required for fd assembly and release (28) .
Since the C-terminal domain of pIII (g3p-D3) is required for fd virion assembly and release, investigation of the role of g3p-D3 in fd infection has not been carried out. Our finding that fd⌬1-pIII CTX , which contains the adsorption and penetration domains of pIII CTX fused to g3p-D3, infects V. cholerae suggests that the C terminus of pIII CTX does not play a role in infection. However, it is also possible that g3p-D3 substituted for this part of pIII CTX in fd⌬1-pIII CTX to allow infection of V. cholerae. Model and colleagues have proposed that g3p-D3 may mediate fusion of the virion with the membrane during entry (28) . Similarly, the role of pVIII in fd infection is not clear. pVIII is synthesized as an inner membrane protein (31) , and during infection, this virion protein has been shown to be "recycled" into the inner membrane of the recipient cell (33, 39) . Our data demonstrate that besides pIII CTX , other CTX proteins are not required for fd infection of V. cholerae. These data could suggest that the major coat protein is not required for infection, or that pVIII's role in fd infection of E. coli is conserved in infection of V. cholerae.
Our findings that the host range of fd can be altered to include a new genus by the relatively simple technique of either adding or substituting an alternative filamentous phage infection protein for pIII fd may prove useful in the development of bacteriophage as therapeutic agents. For example, it may be possible to create a library of fd-based phages that are able to infect a broad range of bacterial pathogens. CTX may also be a useful starting platform from which to engineer such libraries. Furthermore, in addition to using CTX-based phages as antimicrobial agents, introduction of antigen-encoding DNA sequences into gIII CTX may enable display of antigenic polypeptides in CTX virions. Production of such recombinant CTXs during human infection by live attenuated V. cholerae vaccine strains could prove to be an effective method for delivery of heterologous antigens to the gut immune system.
